Explore All Our Expert Guides and Research papers in One Place

Featured Web News

CellCarta’s HALO AI global deployment set to supercharge quantitative image analysis offering

More info

Featured Web News

CellCarta Expands its Biomarker Capabilities for Clinical Trials by adding Olink Technology to its Global Services

Proteomics/Mass Spectrometry

More info

Featured Web News

CellCarta Launches Advanced AI-Powered Spatial Biology Data for Clinical Trials

Histopathology

More info

CellTalk Blog

What steps to follow when developing multiplex IHC assays

More info

Brochures & Infographics

Genomic Assay List

April 15, 2026

More info

Posters

Fit-for-purpose validation and inter-laboratory cross-validation of a TBNK flow cytometry assay with improved B cell monitoring capabilities

April 14, 2026

More info

Posters

Understanding Protein Normalization: A Case Study in PBMC Fit-for-Purpose Validation by MS

April 14, 2026

More info

CellTalk Blog

Rescuing a Pilot Study: How a Coordinated Response From CellCarta Kept a Critical Program on Track

April 14, 2026

More info

CellTalk Blog

Emerging Biomarkers Shaping the Next Generation of ADC Therapies

April 14, 2026

More info

CellTalk Blog

Meeting a Critical Deadline: How CellCarta’s California Laboratory Team Accelerated Assay Development and Clinical Testing to Deliver Ahead of Schedule

April 14, 2026

More info

Brochures & Infographics

Flow Cytometry Panels

April 10, 2026

Flow Cytometry

More info

Press Releases

CellCarta and Pillar Biosciences Announce Multi-Year Global Strategic Partnership to Expand Rapid, Decentralized Tumor Profiling for Oncology Clinical Trials

April 7, 2026

More info

News

CellCarta and Lunit Announce Strategic Collaboration to Accelerate AI-Enabled Digital Pathology for Companion Diagnostic Programs

March 30, 2026

More info

Show the filters